Optimi Health (OPTH) Fundamentals 2026 — Revenue Analysis | SniperIQ
Optimi Health (OPTH) is a CA-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of
5M, trading at $4.61 on the NASDAQ. This SniperIQ fundamentals page covers Optimi Health's valuation, profitability (net margin -2330.1%), revenue (CAD 426,904 in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap
5M
Net Margin-2330.1%
Revenue (FY25)CAD 426,904
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Optimi Health's market cap?
Optimi Health (OPTH) has a market capitalization of approximately
5M, trading at $4.61 on the NASDAQ. Market cap moves with the live share price.
What is Optimi Health's P/E ratio?
Optimi Health's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 6.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Optimi Health?
Optimi Health runs a net profit margin of -2330.1%, a gross margin of -1323.7%, and an operating margin of -2164.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Optimi Health generate?
Optimi Health reported revenue of CAD 426,904 for fiscal year 2025, with net income of -CAD 4M and earnings per share (EPS) of -1.1640000000000001. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Optimi Health pay a dividend?
Optimi Health does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Optimi Health financially healthy?
Optimi Health carries a debt-to-equity ratio of 1.86x and a current ratio of 0.06x, with a market beta of 1.59. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Optimi Health a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Optimi Health (OPTH) the key facts are: market cap
5M, revenue CAD 426,904, 52-week range 4-6.4. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Optimi Health's full fundamentals live
Get Optimi Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.